Severity of haemolytic disease of the fetus and newborn in patients with a history of intrauterine transfusions in a previous pregnancy: A nationwide retrospective cohort study
Open Access
- 24 September 2023
- journal article
- research article
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 131 (6) , 769-776
Abstract
Objective: Pregnant women who received at least one intrauterine transfusion (IUT) for haemolytic disease of the fetus and newborn (HDFN) in the preceding pregnancy are presumed to have a high likelihood of requiring IUTs again, often starting at an earlier gestational age. Our aim was to quantify these risks in a large national cohort.Design: Retrospective cohort study of a nationwide Dutch database.Setting: The Netherlands.Population: All women treated in The Netherlands with IUTs for Rhesus D (RhD)‐ or Kell‐mediated HDFN between 1999 and 2017 and their follow‐up pregnancies were included. Pregnancies with an antigen‐negative fetus were excluded.Methods: Electronic patient files were searched for the number and gestational age of each IUT, and analysed using descriptive statistics and linear regression.Main outcome measures: Percentage of women requiring one or more IUTs again in the subsequent pregnancy, and gestational age at first IUT in both pregnancies.Results: Of the 321 women in our study population, 21% (69) had a subsequent ongoing pregnancy at risk. IUTs were administered in 86% (59/69) of cases. In subsequent pregnancies, the median gestational age at first IUT was 3 weeks earlier (interquartile range −6.8 to 0.4) than in the preceding pregnancy.Conclusions: Our study shows that pregnant women with a history of IUTs in the previous pregnancy are highly likely to require IUTs again, and on average 3 weeks earlier. Clinicians need to be aware of these risks and ensure timely referral, and close surveillance from early pregnancy onwards. Additionally, for women with a history of IUT and their caregivers, this information is essential to enable adequate preconception counselling.Keywords
This publication has 15 references indexed in Scilit:
- Antigen specificity determines anti‐red blood cell IgG‐Fc alloantibody glycosylation and thereby severity of haemolytic disease of the fetus and newbornBritish Journal of Haematology, 2016
- Complications of intrauterine intravascular blood transfusion: lessons learned after 1678 proceduresUltrasound in Obstetrics & Gynecology, 2016
- Low anti‐RhD IgG‐Fc‐fucosylation in pregnancy: a new variable predicting severity in haemolytic disease of the fetus and newbornBritish Journal of Haematology, 2014
- Noninvasive fetal blood group genotyping of rhesus D, c, E and of K in alloimmunised pregnant women: evaluation of a 7-year clinical experienceBJOG: An International Journal of Obstetrics & Gynaecology, 2011
- Risk factors for RhD immunisation despite antenatal and postnatal anti‐D prophylaxisBJOG: An International Journal of Obstetrics & Gynaecology, 2009
- An Audit of Outcome in Intravascular Transfusions Using the Intrahepatic Portion of the Fetal Umbilical Vein Compared to CordocentesisFetal Diagnosis and Therapy, 2006
- Intravenous Fetal Exchange Transfusion before 22 Weeks of Gestation in Early and Severe Red-Cell Fetomaternal AlloimmunizationFetal Diagnosis and Therapy, 2003
- Paternal leukocyte alloimmunization as a treatment for hemolytic disease of the newborn in a rabbit modelAmerican Journal of Obstetrics and Gynecology, 2002
- Clinical value of an antibody-dependent cell-mediated cytotoxicity assay in the management of Rh D alloimmunizationAmerican Journal of Obstetrics and Gynecology, 2001
- Evidence for the Protective Effect of Maternal FcR‐Blocking IgG Alloantibodies HLA‐DR in Rh D‐Haemolytic Disease of the NewbornVox Sanguinis, 1993